Studies on the metabolic fate of n-3 polyunsaturated fatty acids

被引:23
|
作者
Ferdinandusse, S
Denis, S
Dacremont, G
Wanders, RA
机构
[1] Univ Amsterdam, Acad Med Ctr, Dept Clin Chem, NL-1100 DE Amsterdam, Netherlands
[2] Univ Amsterdam, Acad Med Ctr, Dept Pediat, NL-1100 DE Amsterdam, Netherlands
[3] Univ Ghent, Dept Pediat, B-9000 Ghent, Belgium
关键词
peroxisomes; beta-oxidation; docosahexaenoic acid; thioesterase; acyl-CoA oxidase;
D O I
10.1194/jlr.M300223-JLR200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Several different processes involved in the metabolic fate of docosahexaenoic acid (DHA, C22:6n-3) and its precursor in the biosynthesis route, C24:6n-3, were studied. In cultured skin fibroblasts, the oxidation rate of [1(-14)C] 24:6n-3 was 2.7 times higher than for [1-C-14]22:6n-3, whereas [1-14C]22:6n-3 was incorporated 7 times faster into different lipid classes than was [1-14C]24:6n-3. When determining the peroxisomal acyl-CoA oxidase activity, similar specific activities for C22:6(n-3)-CoA and C24:6(n-3)-CoA were found in mouse kidney peroxisomes. Thioesterase activity was measured for both substrates in mouse kidney peroxisomes as well as mitochondria, and C22:6(n-3)-CoA was hydrolyzed 1.7 times faster than C24:6(n-3)-CoA. jlr These results imply that the preferred metabolic fate of C24:6(n-3)-CoA, after its synthesis in the endoplasmic reticulum (ER), is to move to the peroxisome, where it is beta-oxidized, producing C22:6(n-3)-CoA. This DHA-CoA then preferentially moves back, probably as free fatty acid, to the ER, where it is incorporated into membrane lipids.-Ferdinandusse, S., S. Denis, G. Dacremont, and R. J. A. Wanders. Studies on the metabolic fate of n-3 polyunsaturated fatty acids. Lipid Res. 2003. 44: 1992-1997.
引用
收藏
页码:1992 / 1997
页数:6
相关论文
共 50 条
  • [31] n-3 polyunsaturated fatty acids to heal the broken heart
    Grenon, Sophie Marlene
    Conte, Michael S.
    [J]. CLINICAL LIPIDOLOGY, 2013, 8 (05) : 497 - 500
  • [32] Therapeutic potential of n-3 polyunsaturated fatty acids in disease
    Fetterman, James W., Jr.
    Zdanowicz, Martin M.
    [J]. AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2009, 66 (13) : 1169 - 1179
  • [33] N-3 polyunsaturated fatty acids and inflammation in the arterial wall
    Yaqoob, P
    Calder, PC
    [J]. EUROPEAN JOURNAL OF MEDICAL RESEARCH, 2003, 8 (08) : 337 - 354
  • [34] n-3 Polyunsaturated fatty acids and mast cell activation
    Wang, Xiaofeng
    Kulka, Marianna
    [J]. JOURNAL OF LEUKOCYTE BIOLOGY, 2015, 97 (05) : 859 - 871
  • [35] n-3 Polyunsaturated fatty acids and human cytokine synthesis
    Endres, S
    [J]. LIPIDS, 1996, 31 : S239 - S242
  • [36] Ingestion of n-3 polyunsaturated fatty acids and ovulation in rats
    Trujillo, EP
    Broughton, KS
    [J]. JOURNAL OF REPRODUCTION AND FERTILITY, 1995, 105 (02): : 197 - 203
  • [37] n-3 polyunsaturated fatty acids supplementation in psoriasis: a review
    Mari N.L.
    Simão A.N.C.
    Dichi I.
    [J]. Nutrire, 42 (1)
  • [38] n-3 Polyunsaturated Fatty Acids and Their Role in Cancer Chemoprevention
    Gu Z.
    Shan K.
    Chen H.
    Chen Y.Q.
    [J]. Current Pharmacology Reports, 2015, 1 (5) : 283 - 294
  • [39] N-3 Polyunsaturated Fatty Acids, Body Fat and Inflammation
    Lund, Anne-Sofie Q.
    Hasselbalch, Ann Louise
    Gamborg, Michael
    Skogstrand, Kristin
    Hougaard, David M.
    Heitmann, Berit L.
    Kyvik, Kirsten O.
    Sorensen, Thorkild I. A.
    Jess, Tine
    [J]. OBESITY FACTS, 2013, 6 (04) : 369 - 379
  • [40] n-3 Polyunsaturated fatty acids and atopy in Korean preschoolers
    Hwang, Inkyung
    Cha, Aeri
    Lee, Hyosun
    Yoon, Hyejung
    Yoon, Taeho
    Cho, Byungmann
    Lee, Suill
    Park, Yongsoon
    [J]. LIPIDS, 2007, 42 (04) : 345 - 349